Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Earlier Start Likely For Europe’s Unified Patent Court

Opt-Outs From The System Will Be Possible

Executive Summary

Having cleared numerous hurdles along the way, the proposed new patent system in Europe now appears to be approaching the home straight, with completion forecast for mid-2022. But will a unitary patent with pan-European effect necessarily be the best option in all cases?

You may also be interested in...



German Court Ruling Opens The Way To New European Patent Court

The long-running process of setting up a new patent court and unitary patent system should shortly be moving into its final phase.

NICE Confirms English Funding For Three COVID-19 Drugs, But Rejects Four Others

There is good news for medicines from Pfizer, GSK and Roche, but MSD, Gilead and AstraZeneca have all appealed against NICE’s decision not to recommend their products for treating COVID-19.

EU Sets New Date For Publication Of Delayed Pharma Revision Proposals

Lengthy legislative procedures are expected after the commission publishes its “pharma package” and the “patent package,” which are now due towards the end of April.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS144877

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel